The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens.EBI
University Of Connecticut
Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.EBI
University Of Connecticut
Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.EBI
Trius Therapeutics
Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.EBI
Trius Therapeutics, San Diego, Ca 92121, United States.
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.EBI
Oklahoma State University
2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 13. Some alkenyl derivatives with high in vitro activity against anaerobic organisms.EBI
Wellcome Research Laboratories
In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B.BDB
Chulalongkorn University
Susceptibility of cord blood antioxidant enzymes glutathione reductase, glutathione peroxidase and glutathione S-transferase to different antibiotics: in vitro approach.BDB
Ondokuz Mayis University